PFE Today - Aug 07: Earnings Beat, Stock Slips

カートのアイテムが多すぎます

ご購入は五十タイトルがカートに入っている場合のみです。

カートに追加できませんでした。

しばらく経ってから再度お試しください。

ウィッシュリストに追加できませんでした。

しばらく経ってから再度お試しください。

ほしい物リストの削除に失敗しました。

しばらく経ってから再度お試しください。

ポッドキャストのフォローに失敗しました

ポッドキャストのフォロー解除に失敗しました

PFE Today - Aug 07: Earnings Beat, Stock Slips

無料で聴く

ポッドキャストの詳細を見る

Hey there! It’s Joey, your friendly longtime investor, here to break down the day. Today we’re talking about Pfizer, and it was a red day for them. The stock slipped about three-quarters of a percent.

So, what went down? Pfizer’s earnings report was actually pretty solid. They beat expectations, which usually gets folks hyped, but today, that wasn’t enough. The stock got hit, even with their announcement of some hefty cost cuts—like $2.5 billion worth. That’s a big number, but it seems like investors weren’t feeling it. There was also some mixed news about their cancer drug from Seagen that didn’t really help boost confidence either.

Now, why the mixed vibes? Well, even though they posted decent earnings, people are still worried about the bigger picture. Pfizer’s been dealing with some slow growth lately, and there's chatter about how they stack up against competitors like Merck. Plus, the fact that one of their higher-ups sold off some stock for over $80K raised a few eyebrows. It’s like, if they’re selling, should we be worried? That kind of stuff gets people thinking twice.

Looking ahead, Pfizer did raise their guidance for the year. That’s a good sign, but it seems like it didn’t do much to lift spirits today. It’s like they’re trying to send a positive message while the stock just isn’t feeling it.

So, yeah, that’s the scoop on Pfizer today. It’s a bit of a mixed bag, but that’s the market for you. Just remember, I’m here to keep you in the loop, not to give financial advice. Stay curious, keep learning, and catch you later!

まだレビューはありません